211 In the index

Noopept NOO

A Russian-developed brain supplement approved there for cognitive problems, chemically related to but different from older brain supplements. Small Russian studies support cognitive benefits in people with impairment, but it isn't approved and hasn't been thoroughly tested in the U.S. or Europe.

Also known as GVS-111, omberacetam

Effects Focus Mood

Routes Oral

Legal status Unscheduled

WADA Not listed

Reported dosing

Limited data

What has been reported in the literature and by users. This is a record of what is done, not a recommendation.

Typical dose 10 mg per dose

Reported range 10-30 mg/day

Route Oral or sublingual

Frequency 1-3 times daily

Duration Ongoing (supplement use), often cycled

Approved as a prescription drug in Russia; sold as an unregulated nootropic supplement in the US.

Where this comes from Russian-language clinical studies; supplement-industry dosing

Human data for this compound is limited. Read the figures above as a record of reported use rather than established dosing.